Abundance Wealth Counselors Increases Stake in SPDR S&P Biotech ETF (NYSEARCA:XBI)

Abundance Wealth Counselors raised its holdings in SPDR S&P Biotech ETF (NYSEARCA:XBI) by 324.9% during the fourth quarter, Holdings Channel.com reports. The fund owned 93,015 shares of the exchange traded fund’s stock after purchasing an additional 71,125 shares during the period. SPDR S&P Biotech ETF comprises about 2.2% of Abundance Wealth Counselors’ holdings, making the stock its 8th largest holding. Abundance Wealth Counselors’ holdings in SPDR S&P Biotech ETF were worth $8,305,000 as of its most recent filing with the SEC.

Other hedge funds and other institutional investors also recently made changes to their positions in the company. Resources Management Corp CT ADV boosted its position in shares of SPDR S&P Biotech ETF by 1,715.8% during the second quarter. Resources Management Corp CT ADV now owns 345 shares of the exchange traded fund’s stock worth $29,000 after purchasing an additional 326 shares in the last quarter. Tyler Stone Wealth Management acquired a new stake in shares of SPDR S&P Biotech ETF during the second quarter worth $33,000. Compass Wealth Management LLC acquired a new stake in shares of SPDR S&P Biotech ETF during the fourth quarter worth $34,000. Fortis Capital Advisors LLC acquired a new stake in SPDR S&P Biotech ETF in the 4th quarter valued at $38,000. Finally, EPG Wealth Management LLC increased its stake in SPDR S&P Biotech ETF by 152.7% in the 3rd quarter. EPG Wealth Management LLC now owns 460 shares of the exchange traded fund’s stock valued at $34,000 after buying an additional 278 shares during the last quarter.

SPDR S&P Biotech ETF Trading Up 0.0 %

Shares of XBI stock opened at $92.69 on Wednesday. SPDR S&P Biotech ETF has a 1 year low of $63.80 and a 1 year high of $103.52. The firm’s fifty day moving average price is $93.14 and its two-hundred day moving average price is $82.48. The firm has a market capitalization of $7.11 billion, a P/E ratio of 11.47 and a beta of 0.97.

About SPDR S&P Biotech ETF

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.